European Projects


Biotransformation of by-products from fruit and vegetable processing industry into valuable bioproducts
Research into the characterisation and selection of by-products derived from the processing of Koji rice, with the aim of obtaining enzymes with high added value in order to obtain a new prototype of detergent that is more effective than the pre-existing ones.


Exploitation of microbial biodiversity for the Discovery and development of novel cosmeceutical agents
Main partner in the exploitation of microbial biodiversity for the discovery and development of novel cosmeceutical agents.


Proteos Biotech S.L. has participated in the ICEX-Next Export Initiation Program, with the support of ICEX and the co-financing of European ERDF funds.
The purpose of this support is to contribute to the international development of the company and its environment.


Exploitation of aromatic plant by-products for the development of novel cosmeceuticals and food supplements
Development of new processes based on eco-friendly technologies for the efficient collection, purification and transformation of active ingredients, as well as the complete chemical characterisation and biological assessment of produced extracts and pure compounds that can be marketed.

National and regional projects


Development of novel and improved enzyme and protein medication and treatments
Technological development of a first prototype of a non-marketable treatment that improves the symptoms of Dupuytren's disease based on previous results of a research carried out and patented by PROTEOS.

Project Torres Quevedo

Obtaining recombinant enzymes with antifibrotic effects from new gene overexpression systems
Within the framework of subsidies to companies to contract doctors to carry out industrial research and/or experimental development projects.


Design, development, assessment and validation of a microemulsion composed of two recombinant enzymes, through its topical application by dispersion of an oil solution on the skin for wound treatment
Participant for the regional Innova Adelante subsidies (Castilla La Mancha) in 2018 and 2021, showing its commitment to innovation, research and development of new R&D projects. Currently immersed in the project.

Proprietary R&D projects


Development of the longest-lasting drug on the market for the treatment of osteoarthritis
Development of a new product for the treatment of osteoarthritis with a substantially higher durability than homologous products on the market.


Development of recombinant enzymes obtained through a new bacterial expression system for use as BAPIS
Generation of new pharmaceutical compounds for the treatment of pathologies related to collagen, hyaluronic acid and adipose tissue, conditions that present a real problem in today's society.


New enzyme combination to improve the treatment of extreme fibrosis
To improve and enhance current techniques for the treatment of diseases caused by an excess of collagen, a condition that presents a real problem in today's society.